Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment
CL Shovlin - Blood reviews, 2010 - Elsevier
Hereditary haemorrhagic telangiectasia, inherited as an autosomal dominant trait, affects
approximately 1 in 5000 people. The abnormal vascular structures in HHT result from …
approximately 1 in 5000 people. The abnormal vascular structures in HHT result from …
[HTML][HTML] Hereditary hemorrhagic telangiectasia: from molecular biology to patient care
S Dupuis‐Girod, S Bailly, H Plauchu - Journal of Thrombosis and …, 2010 - Elsevier
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular disorder
characterized by severe and recurrent nosebleeds, mucocutaneous telangiectases, and, in …
characterized by severe and recurrent nosebleeds, mucocutaneous telangiectases, and, in …
[HTML][HTML] Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective
A Kritharis, H Al-Samkari, DJ Kuter - Haematologica, 2018 - ncbi.nlm.nih.gov
Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu
syndrome, is an autosomal dominant disorder that causes abnormal blood vessel formation …
syndrome, is an autosomal dominant disorder that causes abnormal blood vessel formation …
Hereditary haemorrhagic telangiectasia: a clinical and scientific review
FS Govani, CL Shovlin - European journal of human genetics, 2009 - nature.com
The autosomal-dominant trait hereditary haemorrhagic telangiectasia (HHT) affects 1 in 5–
8000 people. Genes mutated in HHT (most commonly for endoglin or activin receptor-like …
8000 people. Genes mutated in HHT (most commonly for endoglin or activin receptor-like …
Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care
H Al-Samkari - Blood, The Journal of the American Society of …, 2021 - ashpublications.org
Hereditary hemorrhagic telangiectasia (HHT) management is evolving because of the
emergence and development of antiangiogenic therapies to eliminate bleeding …
emergence and development of antiangiogenic therapies to eliminate bleeding …
Genetic abnormalities in hereditary hemorrhagic telangiectasia
DA Marchuk - Current opinion in hematology, 1998 - journals.lww.com
Hereditary hemorrhagic telangiectasia (HHT), or Rendu-Osler-Weber disease, is an
autosomal dominant disorder of localized angiodysplasia, although it is sometimes …
autosomal dominant disorder of localized angiodysplasia, although it is sometimes …
[HTML][HTML] Hereditary hemorrhagic telangiectasia
J McDonald, DA Stevenson - 2021 - europepmc.org
Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple
arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct …
arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct …
Optimal management of hereditary hemorrhagic telangiectasia
Hereditary hemorrhagic telangiectasia (HHT), also known by the eponym Osler–Weber–
Rendu syndrome, is a group of related disorders inherited in an autosomal dominant fashion …
Rendu syndrome, is a group of related disorders inherited in an autosomal dominant fashion …
[HTML][HTML] Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis
J McDonald, P Bayrak-Toydemir, RE Pyeritz - Genetics in medicine, 2011 - Elsevier
Abstract Abstract Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) is
a disorder of development of the vasculature characterized by telangiectases and …
a disorder of development of the vasculature characterized by telangiectases and …
Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia
L Ruiz-Llorente, E Gallardo-Vara, E Rossi… - Expert opinion on …, 2017 - Taylor & Francis
ABSTRACT Introduction: Hereditary Haemorrhagic Telangiectasia (HHT) is as an autosomal
dominant trait characterized by frequent nose bleeds, mucocutaneous telangiectases …
dominant trait characterized by frequent nose bleeds, mucocutaneous telangiectases …